TRMT112P3

Across TCGA pan-cancer cohorts, TRMT112P3 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated TRMT112P3 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher TRMT112P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRMT112P3 expression acts as an unfavorable survival marker, although some lineages such as LGG and UCS show a favorable association.

KICH, LUSC, and LGG are the cancer types where TRMT112P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.876	1.000	.001	81	view →
LUSC	DFS	Quartile	II,III,IV	0.182	0.639	.002	51	view →
LGG	OS	Median	All	0.520	0.361	<.001	41	view →
LUAD	DFS	Median	All	0.237	0.465	.001	26	view →
UCS	DFS	Quartile	II,III,IV	0.600	0.193	.012	24	view →
CESC	OS	Median	All	0.864	0.745	.005	22	view →
UVM	OS	Tertile	III,IV	0.480	0.879	.024	20	view →
ACC	OS	Tertile	IV	0.403	0.814	.008	20	view →
THCA	DFS	Median	All	0.977	0.871	.009	19	view →
SARC	OS	Median	All	0.612	0.792	.003	19	view →
KIRC	DFS	Median	All	0.484	0.716	.001	16	view →
STAD	DFS	Median	All	0.612	0.797	.012	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

TRMT112P3–KICH (OS)

Open the KICH breakdown →